Niloofar Rahmani

Array ( [id] => 4444959 [patent_doc_number] => 07863290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics' [patent_app_type] => utility [patent_app_number] => 12/028999 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9114 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863290.pdf [firstpage_image] =>[orig_patent_app_number] => 12028999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867748 [patent_doc_number] => 20080146807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Indazole-carboxamide compounds as 5-HT4 receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/012579 [patent_app_country] => US [patent_app_date] => 2008-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23943 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146807.pdf [firstpage_image] =>[orig_patent_app_number] => 12012579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833990 [patent_doc_number] => 20080132537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'TROPANE DERIVATIVES USEFUL IN THERAPY' [patent_app_type] => utility [patent_app_number] => 12/023334 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16038 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132537.pdf [firstpage_image] =>[orig_patent_app_number] => 12023334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026261 [patent_doc_number] => 20110053953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613' [patent_app_type] => utility [patent_app_number] => 12/526161 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10711 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053953.pdf [firstpage_image] =>[orig_patent_app_number] => 12526161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833989 [patent_doc_number] => 20080132536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'PYRAZOLO [3,4-B] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/022372 [patent_app_country] => US [patent_app_date] => 2008-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78563 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132536.pdf [firstpage_image] =>[orig_patent_app_number] => 12022372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764703 [patent_doc_number] => 20080175914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Pyrazolo[3,4-b]Pyridine Compounds, and their Use as Phosphodiesterase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/013529 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79160 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175914.pdf [firstpage_image] =>[orig_patent_app_number] => 12013529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 112078 [patent_doc_number] => 07718670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Quinuclidine amide derivatives' [patent_app_type] => utility [patent_app_number] => 11/970698 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18199 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718670.pdf [firstpage_image] =>[orig_patent_app_number] => 11970698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 63045 [patent_doc_number] => 07763636 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'N-(arylalkyl)-1H-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 11/970886 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20578 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763636.pdf [firstpage_image] =>[orig_patent_app_number] => 11970886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823239 [patent_doc_number] => 20080227777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Pyrazolopyridine derivatives as inhibitors of beta-Adrenergic Receptor Kinase 1' [patent_app_type] => utility [patent_app_number] => 11/961282 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10161 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227777.pdf [firstpage_image] =>[orig_patent_app_number] => 11961282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834157 [patent_doc_number] => 20080132704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => '3-Substituted quinuclidines and their use' [patent_app_type] => utility [patent_app_number] => 12/004022 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8168 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132704.pdf [firstpage_image] =>[orig_patent_app_number] => 12004022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537945 [patent_doc_number] => 20100204264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'POLYMORPHIC FORM OF GRANISETRON BASE, METHODS FOR OBTAINING IT AND FORMULATION CONTAINING IT' [patent_app_type] => utility [patent_app_number] => 12/664153 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2864 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204264.pdf [firstpage_image] =>[orig_patent_app_number] => 12664153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4698964 [patent_doc_number] => 20080221148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR' [patent_app_type] => utility [patent_app_number] => 11/962044 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96132 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221148.pdf [firstpage_image] =>[orig_patent_app_number] => 11962044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867546 [patent_doc_number] => 20080146605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'PREPARATION AND UTILITY OF CCR5 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 11/960171 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29687 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146605.pdf [firstpage_image] =>[orig_patent_app_number] => 11960171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4444954 [patent_doc_number] => 07863289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Compounds and methods for kinase modulation, and indications therefor' [patent_app_type] => utility [patent_app_number] => 11/960590 [patent_app_country] => US [patent_app_date] => 2007-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43029 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/863/07863289.pdf [firstpage_image] =>[orig_patent_app_number] => 11960590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386222 [patent_doc_number] => 08263617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 12/520236 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6497 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465736 [patent_doc_number] => 20090325936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'IMIDAZOPYRIDINE ANALOGS AS CB2 RECEPTOR MODULATORS, USEFUL IN THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/519789 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38766 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325936.pdf [firstpage_image] =>[orig_patent_app_number] => 12519789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386217 [patent_doc_number] => 08263612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Viral inhibitors' [patent_app_type] => utility [patent_app_number] => 11/957017 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13962 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11957017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6494482 [patent_doc_number] => 20100093751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor' [patent_app_type] => utility [patent_app_number] => 12/520004 [patent_app_country] => US [patent_app_date] => 2007-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9600 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093751.pdf [firstpage_image] =>[orig_patent_app_number] => 12520004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453235 [patent_doc_number] => 20090069272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Composition for treating bone disorders' [patent_app_type] => utility [patent_app_number] => 12/001318 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5524 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069272.pdf [firstpage_image] =>[orig_patent_app_number] => 12001318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960672 [patent_doc_number] => 20080275097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Non-nucleoside reverse transcriptase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/999686 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45365 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275097.pdf [firstpage_image] =>[orig_patent_app_number] => 11999686 [rel_patent_id] =>[rel_patent_doc_number] =>)